NASDAQ Biotechnology Index investment & finance definition

A measure of the performance of NASDAQ-listed companies involved in biotechnology research that is targeted to discover and develop treatments for human diseases. The index began on November 1993 with a base of 200.00. It is calculated using a modified capitalization-weighted methodology.